| Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Nicorette Invisi 10 mg/16 h | transdermales Pflaster | Transdermales Therapeutisches System (Nicotine 15.75 mg) | N07BA01 | PI |
| 02 | Nicorette Invisi 15 mg/ 16 h | transdermales Pflaster | Transdermales Therapeutisches System (Nicotine 23.62 mg) | N07BA01 | PI |
| 03 | Nicorette Invisi 25 mg/ 16 h | transdermales Pflaster | Transdermales Therapeutisches System (Nicotine 39.37 mg) | N07BA01 | PI |
